Chordate Medical Holding AB (publ) (STO:CMH)
6.32
-0.10 (-1.56%)
May 2, 2025, 3:56 PM CET
STO:CMH Revenue
In the year 2024, Chordate Medical Holding AB had annual revenue of 2.44M SEK with 39.85% growth. Chordate Medical Holding AB had revenue of 86.08K in the quarter ending December 31, 2024, a decrease of -86.78%.
Revenue
2.44M
Revenue Growth
+39.85%
P/S Ratio
7.09
Revenue / Employee
814.32K
Employees
3
Market Cap
17.33M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 2.44M | 696.10K | 39.85% |
Dec 31, 2023 | 1.75M | 1.64M | 1,509.77% |
Dec 31, 2022 | 108.52K | -2.07M | -95.03% |
Dec 31, 2021 | 2.18M | -1.43M | -39.57% |
Dec 31, 2020 | 3.61M | 663.38K | 22.49% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Swedish Orphan Biovitrum AB | 26.24B |
Sectra AB | 3.30B |
Getinge AB | 35.57B |
Camurus AB | 1.87B |
Medicover AB | 23.56B |
AddLife AB | 10.42B |
Vitrolife AB | 3.61B |
Bonesupport Holding AB | 997.85M |